Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Abbasi S, Fani M, Sayar S, Radmanesh E, Jelvay S, Pahlavanzadeh B, Arizavi Z, Esmaeelian H, Asadi M, Babaeian N, Yoosefi RP (2023) The effects of vitamin D3 and N-acetylcysteine administration in patients with COVID-19 hospitalization in the Iranian population. Int J Med Lab. https://doi.org/10.18502/ijml.v10i3.13746
2. Bychinin MV, Klypa TV, Mandel IA et al (2022) Effect of vitamin D3 supplementation on cellular immunity and inflammatory markers in COVID-19 patients admitted to the ICU. Sci Rep 12(1):18604
3. Cannata-Andía JB, Díaz-Sottolano A, Fernández P et al (2022) A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial. BMC Med 20(1):83
4. Cochrane Methods Bias (2023) RoB 2: a revised Cochrane risk-of-bias tool for randomized trials. https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. Accessed 15 July 2024
5. De Niet S, Trémège M, Coffiner M et al (2022) Positive effects of vitamin D supplementation in patients hospitalized for COVID-19: a randomized, double-blind, placebo-controlled trial. Nutrients 14(15):3048